Figure 1

Posterior Reversible Leukoencephalopathy Syndrome in a patient after second dose of Rituximab for treatment of resistant Thrombotic Thrombocytopenic Purpura

Sabaa Asif*, Sumbal Nasir Mahmood and Osama Kunwer Naveed

Published: 16 February, 2018 | Volume 2 - Issue 1 | Pages: 001-004

jcn-aid1010-g001

Figure 1:

Read Full Article HTML DOI: 10.29328/journal.jcn.1001010 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?